Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Results 1 - 14 of 14

Recs

2
Member Avatar jschinagle (< 20) Submitted: 5/13/2013 4:26:19 PM : Underperform Start Price: $1.07 ENZN Score: +6.50

nothing left after large liquidating dividend

Recs

0
Member Avatar Hotpicks101 (28.84) Submitted: 1/21/2011 6:11:35 PM : Outperform Start Price: $2.86 ENZN Score: -117.04

Klarman. Cheap.

Recs

0
Member Avatar jsgant13 (99.33) Submitted: 9/13/2010 1:01:00 PM : Outperform Start Price: $2.71 ENZN Score: -137.53

baupost, deej and value

Recs

0
Member Avatar NoIcons (< 20) Submitted: 2/28/2010 6:33:42 PM : Outperform Start Price: $2.32 ENZN Score: -131.48

outperform

Recs

0
Member Avatar healthcare1 (< 20) Submitted: 1/17/2009 5:04:27 AM : Outperform Start Price: $1.54 ENZN Score: -167.56

it has a unique drug delivery system and activist shareholders

Recs

0
Member Avatar mjan706 (69.15) Submitted: 9/22/2008 1:44:10 AM : Outperform Start Price: $1.95 ENZN Score: -105.17

An Icahn portfolio stock.

Recs

0
Member Avatar hennessy7 (64.21) Submitted: 5/26/2008 9:12:50 AM : Outperform Start Price: $2.19 ENZN Score: -97.59

I like the sector. This is a sector pick as I have done little DD on this stock. I think small biotech has been hit hard, and the cancer market, in particular, is going to turn around. Plus, I do not see too many incredible investments in other sectors so I am sticking to high risk/ high reward opportunities.

Recs

0
Member Avatar WonderWolf (63.02) Submitted: 5/20/2008 11:48:35 PM : Outperform Start Price: $2.20 ENZN Score: -93.36

Working on 2 cancer drugs and will be the big winner!!

Recs

0
Member Avatar Addgirl48 (59.70) Submitted: 3/29/2008 11:21:19 AM : Outperform Start Price: $2.30 ENZN Score: -108.07

People all ways needing pills so Pharmaceuticals all ways geting business and all ways will

Recs

0
Member Avatar djinsanity (< 20) Submitted: 2/9/2008 12:17:36 PM : Outperform Start Price: $2.01 ENZN Score: -98.78

PEG-SN38 showed anti-tumor activity in resistant pre-clinical models, FDA approval for DepoCyt, leader in stem cell research, I can see it doing phenomenal

Recs

0
Member Avatar henncoop (86.58) Submitted: 3/7/2007 11:04:59 AM : Outperform Start Price: $2.04 ENZN Score: -94.88

low PE &amp; a good choice for a play in this sector

Recs

0
Member Avatar pbqstraining (< 20) Submitted: 1/12/2007 10:52:34 PM : Outperform Start Price: $2.12 ENZN Score: -93.37

NICE PIPELINE

Recs

0
Member Avatar j3nzsrfs (< 20) Submitted: 11/25/2006 10:29:17 PM : Outperform Start Price: $2.07 ENZN Score: -95.00

New cancer treatment

Recs

0
Member Avatar MadisonClub1 (< 20) Submitted: 11/22/2006 8:11:36 PM : Outperform Start Price: $2.07 ENZN Score: -94.95

All looks bad for it but ....just a feeling

Results 1 - 14 of 14

Featured Broker Partners


Advertisement